AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $124,000 | +103.3% | 8,192 | 0.0% | 0.00% | – |
| Q2 2022 | $61,000 | -18.7% | 8,192 | 0.0% | 0.00% | – |
| Q1 2022 | $75,000 | +29.3% | 8,192 | 0.0% | 0.00% | – |
| Q4 2021 | $58,000 | -37.6% | 8,192 | 0.0% | 0.00% | – |
| Q3 2021 | $93,000 | -29.0% | 8,192 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $131,000 | -10.3% | 8,192 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $146,000 | +31.5% | 8,192 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $111,000 | +15.6% | 8,192 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $96,000 | -20.7% | 8,192 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $121,000 | +9.0% | 8,192 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $111,000 | +4.7% | 8,192 | +87.5% | 0.00% | 0.0% |
| Q4 2019 | $106,000 | +26.2% | 4,370 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $84,000 | -34.9% | 4,370 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $129,000 | -38.0% | 4,370 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $208,000 | +31.6% | 4,370 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $158,000 | -41.3% | 4,370 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $269,000 | +35.2% | 4,370 | +48.6% | 0.00% | +100.0% |
| Q2 2018 | $199,000 | +25.2% | 2,940 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $159,000 | -9.7% | 2,940 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $176,000 | – | 2,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |